{"entity":{"type":"insider","cik":"0001333277","url":"/insider/0001333277","json_url":"/insider/0001333277.json","name":"Quinlan Paul T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":61,"n_filings":52,"first":"2012-01-12","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Quinlan Paul T","source":"filing","n_filings":52,"first_seen":"2012-01-12","last_seen":"2026-08-14"}],"transactions":[{"id":9206616,"accession":"0000907654-26-000077","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000907654-26-000077","line_url":"/filing/0000907654-26-000077","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52000.0,"shares_display":"52,000","price_per_share":108.48863354038461,"price_display":"108.49","price_state":"stated","total_value":5641408.9441,"total_display":"5,641,408.94","total_whole":"5,641,409","shares_owned_after":44074.0,"shares_owned_after_display":"44,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-14","scope":"insider","n_lines":6},{"id":5794901,"accession":"0000907654-26-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000907654-26-000060","line_url":"/filing/0000907654-26-000060#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":69.69,"price_display":"69.69","price_state":"stated","total_value":51082.77,"total_display":"51,082.77","total_whole":"51,083","shares_owned_after":31034.0,"shares_owned_after_display":"31,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-15","scope":"insider"},{"id":6124664,"accession":"0000907654-26-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000907654-26-000029","line_url":"/filing/0000907654-26-000029#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"Oruka Therapeutics, Inc.","issuer_ticker":"ORKA","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":41.3,"price_display":"41.30","price_state":"stated","total_value":30272.9,"total_display":"30,272.90","total_whole":"30,273","shares_owned_after":31767.0,"shares_owned_after_display":"31,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider"},{"id":2244744,"accession":"0001062993-24-000923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-000923","line_url":"/filing/0001062993-24-000923#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.5796,"price_display":"23.58","price_state":"stated","total_value":117898.0,"total_display":"117,898.00","total_whole":"117,898","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-16","scope":"insider"},{"id":8467786,"accession":"0001062993-23-022636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-022636","line_url":"/filing/0001062993-23-022636#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.9805,"price_display":"21.98","price_state":"stated","total_value":109902.5,"total_display":"109,902.50","total_whole":"109,903","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-15","scope":"insider"},{"id":8751561,"accession":"0001062993-23-021137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-021137","line_url":"/filing/0001062993-23-021137#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.3778,"price_display":"17.38","price_state":"stated","total_value":86889.0,"total_display":"86,889.00","total_whole":"86,889","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8318144,"accession":"0001062993-23-019547","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-019547","line_url":"/filing/0001062993-23-019547#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.7596,"price_display":"13.76","price_state":"stated","total_value":68798.0,"total_display":"68,798.00","total_whole":"68,798","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":8622325,"accession":"0001062993-23-018278","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-23-018278","line_url":"/filing/0001062993-23-018278","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53000.0,"shares_display":"53,000","price_per_share":16.870581132075472,"price_display":"16.87","price_state":"stated","total_value":894140.8,"total_display":"894,140.80","total_whole":"894,141","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-19","scope":"insider","n_lines":3},{"id":8013568,"accession":"0001062993-23-016606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-016606","line_url":"/filing/0001062993-23-016606#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.9101,"price_display":"11.91","price_state":"stated","total_value":59550.5,"total_display":"59,550.50","total_whole":"59,551","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-16","scope":"insider"},{"id":8751329,"accession":"0001062993-23-014924","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-014924","line_url":"/filing/0001062993-23-014924#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.81,"price_display":"11.81","price_state":"stated","total_value":59050.0,"total_display":"59,050.00","total_whole":"59,050","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-14","filed_date":"2023-07-14","scope":"insider"},{"id":8428121,"accession":"0001062993-23-014259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-014259","line_url":"/filing/0001062993-23-014259#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.05,"price_display":"10.05","price_state":"stated","total_value":50250.0,"total_display":"50,250.00","total_whole":"50,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-06-30","scope":"insider"},{"id":8672457,"accession":"0001062993-23-011430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-011430","line_url":"/filing/0001062993-23-011430#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":10.3662,"price_display":"10.37","price_state":"stated","total_value":51831.0,"total_display":"51,831.00","total_whole":"51,831","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":4802004,"accession":"0001555667-17-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-17-000007","line_url":"/filing/0001555667-17-000007#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"TerraVia Holdings, Inc.","issuer_ticker":"TVIA","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":0.8093,"price_display":"0.81","price_state":"stated","total_value":20232.5,"total_display":"20,232.50","total_whole":"20,233","shares_owned_after":218403.0,"shares_owned_after_display":"218,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-13","scope":"insider"},{"id":2688571,"accession":"0001555667-16-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-16-000092","line_url":"/filing/0001555667-16-000092#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"TerraVia Holdings, Inc.","issuer_ticker":"TVIA","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.5528,"price_display":"2.55","price_state":"stated","total_value":25528.0,"total_display":"25,528.00","total_whole":"25,528","shares_owned_after":120403.0,"shares_owned_after_display":"120,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-14","filed_date":"2016-10-14","scope":"insider"},{"id":2294428,"accession":"0001555667-16-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-16-000091","line_url":"/filing/0001555667-16-000091#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"TerraVia Holdings, Inc.","issuer_ticker":"TVIA","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3124.0,"shares_display":"3,124","price_per_share":2.6016,"price_display":"2.60","price_state":"stated","total_value":8127.3984,"total_display":"8,127.40","total_whole":"8,127","shares_owned_after":130528.0,"shares_owned_after_display":"130,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-16","filed_date":"2016-09-16","scope":"insider"},{"id":2688565,"accession":"0001555667-16-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-16-000090","line_url":"/filing/0001555667-16-000090#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"TerraVia Holdings, Inc.","issuer_ticker":"TVIA","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":2.7355,"price_display":"2.74","price_state":"stated","total_value":4272.851,"total_display":"4,272.85","total_whole":"4,273","shares_owned_after":133652.0,"shares_owned_after_display":"133,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-15","scope":"insider"},{"id":2971713,"accession":"0001555667-16-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-16-000068","line_url":"/filing/0001555667-16-000068#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4686.0,"shares_display":"4,686","price_per_share":1.636,"price_display":"1.64","price_state":"stated","total_value":7666.296,"total_display":"7,666.30","total_whole":"7,666","shares_owned_after":133007.0,"shares_owned_after_display":"133,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-10","filed_date":"2016-03-14","scope":"insider"},{"id":2778916,"accession":"0001555667-16-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-16-000060","line_url":"/filing/0001555667-16-000060#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":1.6646,"price_display":"1.66","price_state":"stated","total_value":2600.1052,"total_display":"2,600.11","total_whole":"2,600","shares_owned_after":75193.0,"shares_owned_after_display":"75,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-09","scope":"insider"},{"id":8166170,"accession":"0001555667-15-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-15-000053","line_url":"/filing/0001555667-15-000053#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":3.1439,"price_display":"3.14","price_state":"stated","total_value":4910.7718,"total_display":"4,910.77","total_whole":"4,911","shares_owned_after":76755.0,"shares_owned_after_display":"76,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-17","filed_date":"2015-09-17","scope":"insider"},{"id":8166167,"accession":"0001555667-15-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-15-000053","line_url":"/filing/0001555667-15-000053#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":3.0822,"price_display":"3.08","price_state":"stated","total_value":4814.3964,"total_display":"4,814.40","total_whole":"4,814","shares_owned_after":78317.0,"shares_owned_after_display":"78,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-15","filed_date":"2015-09-17","scope":"insider"},{"id":8263868,"accession":"0001555667-15-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-15-000036","line_url":"/filing/0001555667-15-000036#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9687.0,"shares_display":"9,687","price_per_share":2.6941,"price_display":"2.69","price_state":"stated","total_value":26097.7467,"total_display":"26,097.75","total_whole":"26,098","shares_owned_after":79879.0,"shares_owned_after_display":"79,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-11","scope":"insider"},{"id":6714214,"accession":"0001555667-14-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-14-000082","line_url":"/filing/0001555667-14-000082#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16562.0,"shares_display":"16,562","price_per_share":8.5278,"price_display":"8.53","price_state":"stated","total_value":141237.4236,"total_display":"141,237.42","total_whole":"141,237","shares_owned_after":70313.0,"shares_owned_after_display":"70,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-11","scope":"insider"},{"id":7040366,"accession":"0001555667-14-000075","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001555667-14-000075","line_url":"/filing/0001555667-14-000075#line-3","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.5469,"price_display":"9.55","price_state":"stated","total_value":57281.4,"total_display":"57,281.40","total_whole":"57,281","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-19","filed_date":"2014-08-19","scope":"insider"},{"id":7040362,"accession":"0001555667-14-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-14-000075","line_url":"/filing/0001555667-14-000075#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":9.1334,"price_display":"9.13","price_state":"stated","total_value":22833.5,"total_display":"22,833.50","total_whole":"22,834","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-15","filed_date":"2014-08-19","scope":"insider"},{"id":6293134,"accession":"0001555667-14-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000064","line_url":"/filing/0001555667-14-000064#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.7962,"price_display":"9.80","price_state":"stated","total_value":58777.2,"total_display":"58,777.20","total_whole":"58,777","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-21","filed_date":"2014-07-22","scope":"insider"},{"id":7080422,"accession":"0001555667-14-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000060","line_url":"/filing/0001555667-14-000060#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.9938,"price_display":"11.99","price_state":"stated","total_value":71962.8,"total_display":"71,962.80","total_whole":"71,963","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-19","filed_date":"2014-06-20","scope":"insider"},{"id":6196208,"accession":"0001555667-14-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000046","line_url":"/filing/0001555667-14-000046#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.203,"price_display":"9.20","price_state":"stated","total_value":55218.0,"total_display":"55,218.00","total_whole":"55,218","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-19","scope":"insider"},{"id":7090072,"accession":"0001555667-14-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000039","line_url":"/filing/0001555667-14-000039#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.3323,"price_display":"11.33","price_state":"stated","total_value":67993.8,"total_display":"67,993.80","total_whole":"67,994","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-21","filed_date":"2014-04-21","scope":"insider"},{"id":6803341,"accession":"0001555667-14-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000032","line_url":"/filing/0001555667-14-000032#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.3926,"price_display":"14.39","price_state":"stated","total_value":86355.6,"total_display":"86,355.60","total_whole":"86,356","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2014-03-19","scope":"insider"},{"id":6447337,"accession":"0001555667-14-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-14-000026","line_url":"/filing/0001555667-14-000026#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3125.0,"shares_display":"3,125","price_per_share":12.207,"price_display":"12.21","price_state":"stated","total_value":38146.875,"total_display":"38,146.88","total_whole":"38,147","shares_owned_after":86875.0,"shares_owned_after_display":"86,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-04","scope":"insider"},{"id":6589804,"accession":"0001555667-14-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-14-000021","line_url":"/filing/0001555667-14-000021#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8239.0,"shares_display":"8,239","price_per_share":11.6133,"price_display":"11.61","price_state":"stated","total_value":95681.9787,"total_display":"95,681.98","total_whole":"95,682","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-24","filed_date":"2014-02-24","scope":"insider"},{"id":7080414,"accession":"0001555667-14-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-14-000005","line_url":"/filing/0001555667-14-000005#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":10.4741,"price_display":"10.47","price_state":"stated","total_value":62844.6,"total_display":"62,844.60","total_whole":"62,845","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-22","scope":"insider"},{"id":4662297,"accession":"0001555667-13-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-13-000089","line_url":"/filing/0001555667-13-000089#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":9.4012,"price_display":"9.40","price_state":"stated","total_value":56407.2,"total_display":"56,407.20","total_whole":"56,407","shares_owned_after":71000.0,"shares_owned_after_display":"71,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-19","filed_date":"2013-12-19","scope":"insider"},{"id":4317413,"accession":"0001555667-13-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-13-000079","line_url":"/filing/0001555667-13-000079#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":8.4098,"price_display":"8.41","price_state":"stated","total_value":50458.8,"total_display":"50,458.80","total_whole":"50,459","shares_owned_after":77000.0,"shares_owned_after_display":"77,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":5227315,"accession":"0001555667-13-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-13-000075","line_url":"/filing/0001555667-13-000075#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":11.47,"price_display":"11.47","price_state":"stated","total_value":68820.0,"total_display":"68,820.00","total_whole":"68,820","shares_owned_after":83000.0,"shares_owned_after_display":"83,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-21","filed_date":"2013-10-21","scope":"insider"},{"id":5184819,"accession":"0001555667-13-000069","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-13-000069","line_url":"/filing/0001555667-13-000069#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":10.7284,"price_display":"10.73","price_state":"stated","total_value":64370.4,"total_display":"64,370.40","total_whole":"64,370","shares_owned_after":89000.0,"shares_owned_after_display":"89,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-19","filed_date":"2013-09-19","scope":"insider"},{"id":4702871,"accession":"0001555667-13-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001555667-13-000057","line_url":"/filing/0001555667-13-000057#line-1","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":739.0,"shares_display":"739","price_per_share":11.89,"price_display":"11.89","price_state":"stated","total_value":8786.71,"total_display":"8,786.71","total_whole":"8,787","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-16","filed_date":"2013-08-16","scope":"insider"},{"id":4998808,"accession":"0001555667-13-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-13-000040","line_url":"/filing/0001555667-13-000040#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":12.043,"price_display":"12.04","price_state":"stated","total_value":36129.0,"total_display":"36,129.00","total_whole":"36,129","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-19","filed_date":"2013-06-21","scope":"insider"},{"id":4478858,"accession":"0001555667-13-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-13-000029","line_url":"/filing/0001555667-13-000029#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.1694,"price_display":"11.17","price_state":"stated","total_value":33508.2,"total_display":"33,508.20","total_whole":"33,508","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-21","scope":"insider"},{"id":5184815,"accession":"0001555667-13-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-13-000025","line_url":"/filing/0001555667-13-000025#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":95000.0,"shares_owned_after_display":"95,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-10","filed_date":"2013-05-10","scope":"insider"},{"id":2634898,"accession":"0001555667-12-000023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-12-000023","line_url":"/filing/0001555667-12-000023#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":10.2439,"price_display":"10.24","price_state":"stated","total_value":20487.8,"total_display":"20,487.80","total_whole":"20,488","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-12","filed_date":"2012-10-12","scope":"insider"},{"id":2316637,"accession":"0001555667-12-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-12-000015","line_url":"/filing/0001555667-12-000015#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.3907,"price_display":"11.39","price_state":"stated","total_value":34172.1,"total_display":"34,172.10","total_whole":"34,172","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-19","filed_date":"2012-09-20","scope":"insider"},{"id":3524647,"accession":"0001555667-12-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001555667-12-000012","line_url":"/filing/0001555667-12-000012#line-2","is_derivative":false,"issuer_cik":"0001311230","issuer_name":"SOLAZYME INC","issuer_ticker":"SZYM","issuer_name_source":null,"issuer_url":"/issuer/0001311230","owner_cik":"0001333277","owner_name":"Quinlan Paul T","owner_display_name":"Quinlan Paul T","owner_url":"/insider/0001333277","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":11.4353,"price_display":"11.44","price_state":"stated","total_value":22870.6,"total_display":"22,870.60","total_whole":"22,871","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-12","filed_date":"2012-09-13","scope":"insider"}],"collapsed":true,"next_cursor":"2012-09-12|3524647","ledger_fault":false,"count":{"value":61,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":61,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":61},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"Oruka Therapeutics, Inc.","url":"/issuer/0000907654","role":"Officer (General Counsel)","n_filings":3,"first_seen":"2026-03-17","last_seen":"2026-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001042074","name":"CymaBay Therapeutics, Inc.","url":"/issuer/0001042074","role":"Officer (General Counsel)","n_filings":9,"first_seen":"2023-05-17","last_seen":"2024-01-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001311230","name":"TerraVia Holdings, Inc.","url":"/issuer/0001311230","role":"Officer (General Counsel)","n_filings":40,"first_seen":"2012-01-12","last_seen":"2017-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001333277","retrieved_at":"2026-08-23T14:20:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}